The reduction in the mRNA levels of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) signifies a robust anti-inflammatory effect of CME, offering a potential mechanism for its protective role against hepatic inflammation associated with obesity. The gene discussed is IL1B; the disease is obesity disorder.